represents a transformative acquisition for Q Holding, creating a market-leading medical device
and component manufacturer offering complete flexible technology solutions for healthcare
produces critical end products that are used on a daily basis in healthcare
settings in applications such as cardiology, general surgery and drug delivery.
Degania, which employs about 1,700 globally, has R&D & manufacturing facilities in Israel, India, France and Slovakia. The company’s Indian arm, Degania
Medical Devices Pvt Ltd, assembles, packs and sterilises urological catheters
at its facility in Gurgaon (Haryana).
“We are delighted to have reached this agreement to purchase Degania.
The businesses are highly complementary and the acquisition represents a critical milestone in diversifying and internationalising the business. It will significantly enhance the value we can deliver to our global customer base thanks to Degania’s strong R&D capabilities in Israel and France and state?of?the?art facilities in Israel, France, India and Slovakia,” commented Randy Ross, chief executive of Q Holding.
markets three brands – Degania
(a premier developer and manufacturer of medical catheters
for global medical device
OEMs); Arthesys (a cardiovascular and peripheral vascular catheter designer and manufacturer specialising in catheters
for stent delivery); and Biometrix (a manufacturer and provider of catheter-related kits for hospitals and health care distributors). Across these segments, Degania
partners with a wide base of global medical device
OEM customers that are market leaders in their respective product categories.
Together, Q Holding
will offer an unprecedented suite of development and manufacturing services, material technologies, analytical tools and industry expertise. The combined business will also offer complete product lifecycle management with assembly, packaging and 510K management for customers’ outsourcing needs with a network of operations that can bring the supply chain close to the consumption point.
Richard Relyea, managing director, 3i North America, added, “3i is pleased to support Q Holding
in this transformative acquisition of Degania.
This combination creates a leader in precision elastomeric medical device
components and assemblies and advances our goal of building the premier global supplier of engineered elastomeric
products for the high growth healthcare
and electrical management markets.”
Company is a leading global manufacturer of highly-engineered precision-moulded elastomeric
components used in a broad range of medical, pharmaceutical and electrical management applications. Q Holding
is vertically integrated with in-house Quadra Tooling & Automation, enabling rapid turnaround and the largest selection of proprietary tooling capabilities in the industry.